Cholecystitis News and Research

RSS
Amgen announces top-line results from motesanib Phase 3 trial against NSCLC

Amgen announces top-line results from motesanib Phase 3 trial against NSCLC

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Contrave added to diet and exercise regimen can induce significant weight loss

Contrave added to diet and exercise regimen can induce significant weight loss

Orexigen's Contrave COR-I trial results published online in journal Lancet

Orexigen's Contrave COR-I trial results published online in journal Lancet

Orexigen Therapeutics announces data from CORDiabetes trial for Contrave

Orexigen Therapeutics announces data from CORDiabetes trial for Contrave

Delaying cholecystectomy in elderly patients can increase cost and mortality

Delaying cholecystectomy in elderly patients can increase cost and mortality

Arizona's smoking ban reduces hospital admissions for stroke, asthma and angina

Arizona's smoking ban reduces hospital admissions for stroke, asthma and angina

Orexigen Therapeutics announces submission of Contrave NDA for treatment of obesity

Orexigen Therapeutics announces submission of Contrave NDA for treatment of obesity

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Research indicates that acute hepatocellular injury in cholelithiasis and cholecystitis without choledocholithiasis is mild and transient

Research indicates that acute hepatocellular injury in cholelithiasis and cholecystitis without choledocholithiasis is mild and transient

Gallbladder emptying in primary sclerosing cholangitis patients

Gallbladder emptying in primary sclerosing cholangitis patients

Nanobac announces Baylor initial results for nanoparticle and gall stone formation study

Nanobac announces Baylor initial results for nanoparticle and gall stone formation study

Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases

Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases

Wide variation in the use of laparoscopic surgery for gall bladder removal

Wide variation in the use of laparoscopic surgery for gall bladder removal

Estrogen therapy may increase risk for gallbladder disease

Estrogen therapy may increase risk for gallbladder disease

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome